Filter
69
Featured
Recommendations
3
Language
Document type
No document type
57
Training Material
4
Manuals
2
Studies & Reports
2
Fact sheets
2
Resource Platforms
1
Guidelines
1
Countries / Regions
Ukraine
5
Eastern Europe
5
Russia
5
Global
5
Western and Central Europe
3
Germany
1
Latin America and the Carribbean
1
Asia
1
Estonia
1
Iran
1
Australia
1
Authors & Publishers
Publication Years
Category
Public Health
14
Capacity Building
2
Countries
1
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Q7: For people with dementia, who should be told of the diagnosis and how should the diagnosis be delivered?
Во Всемирном отчёте (World Alzheimer Report) 2010 мы основываемся на данных отчёта 2009 года (World Alzheimer Report 2009), чтобы определить расходы, связанные с деменцией в наших странах. Отчё
...
November 3, 2009https://doi.org/10.1371/journal.pmed.1000176
PLoS Med 6(11): e1000176. https://doi.org/10.1371/journal.pmed.1000176
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b158 (Published 05 February 2009)
Cite this as: BMJ 2009;338:b158
Correspondence to: A Burns alistair.burns@manchester.ac.uk
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
